Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2010 | 07-2009 | 07-2008 | 07-2007 | 07-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,193 | 4,214 | 2,024 | 736 | 4,720 |
| Marketable Securities | N/A | N/A | 4,608 | 708 | N/A |
| Receivables | 333 | 143 | 835 | 8 | 58 |
| Inventories | 752 | 422 | 370 | 243 | 172 |
| TOTAL | $3,424 | $4,848 | $7,890 | $1,694 | $5,067 |
| Non-Current Assets | |||||
| PPE Net | 697 | 857 | 1,035 | 969 | 353 |
| Intangibles | 1,873 | 1,945 | 2,016 | 2,176 | 2,137 |
| Other Non-Current Assets | 0 | 0 | 0 | 23 | 409 |
| TOTAL | $2,570 | $2,801 | $3,051 | $3,168 | $2,899 |
| Total Assets | $5,994 | $7,649 | $10,941 | $4,862 | $7,965 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 329 | 368 | 596 | 423 | 334 |
| Accrued Expenses | 244 | 192 | 126 | 77 | 75 |
| TOTAL | $583 | $563 | $982 | $502 | $412 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10 | N/A | 257 | N/A | N/A |
| TOTAL | $16 | $19 | $16 | $N/A | $N/A |
| Total Liabilities | $599 | $583 | $997 | $502 | $412 |
| Shareholders' Equity | |||||
| Common Shares | 355 | 38,499 | 35,436 | 26,520 | 25,802 |
| Retained earnings | -45,261 | N/A | -31,433 | -24,893 | -20,238 |
| Other shareholders' equity | 0 | -35,999 | 1,785 | 246 | 246 |
| TOTAL | $5,394 | $7,066 | $9,944 | $4,360 | $7,553 |
| Total Liabilities And Equity | $5,994 | $7,649 | $10,941 | $4,862 | $7,965 |